bayer, cdsco, central drugs standard control organisation, clinical trials, coronavirus, drugs consultative committee, eli lilly, good manufacturing practices, health, ihh healthcare, india drug regulatory authority, india health ministry, journalist, journalists, mounjaro, national pharmaceutical pricing authority, news, novo nordisk, pharma, pharma industry regulations, pharmaceutical industry, tirzepatide, tokyo district court, type 2 diabetes, union health ministry, cipla, active pharmaceutical ingredients, drug manufacturers, covid vaccines, niti aayog, pharmexcil, drug exports, biosimilars